NCT05382091View on ClinicalTrials.gov

Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 15, 2026

Primary Completion Date

January 15, 2028

Study Completion Date

January 15, 2029

Conditions
Opioid Use Disorder
Interventions
DRUG

naltrexone implant

3.6 g per implant set each containing 60% naltrexone

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

New York State Psychiatric Institute

OTHER

collaborator

Columbia University

OTHER

collaborator

The Emmes Company, LLC

INDUSTRY

collaborator

University at Buffalo

OTHER

lead

Go Medical Industries Pty Ltd

INDUSTRY